Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Datos Estadísticas

Lista de

medroxyprogesterone acetate

35

"Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions" (2013) Spallanzani, R.G.;Dalotto-Moreno, T.;Raffo Iraolagoitia, X.L. (...)Zwirner, N.W. Cancer Immunology, Immunotherapy. 62(12):1781-1795

"Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions" (2013) Spallanzani, R.G.;Dalotto-Moreno, T.;Raffo Iraolagoitia, X.L. (...)Zwirner, N.W. Cancer Immunology, Immunotherapy. 62(12):1781-1795

"Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions" (2013) Spallanzani, R.G.;Dalotto-Moreno, T.;Raffo Iraolagoitia, X.L. (...)Zwirner, N.W. Cancer Immunology, Immunotherapy. 62(12):1781-1795

"Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy" (2013) Díaz Flaqué, M.C.;Galigniana, N.M.;Béguelin, W. (...)Elizalde, P.V. Breast Cancer Research. 15(6)

"Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy" (2013) Díaz Flaqué, M.C.;Galigniana, N.M.;Béguelin, W. (...)Elizalde, P.V. Breast Cancer Research. 15(6)

"PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer" (2012) Riggio, M.;Polo, M.L.;Blaustein, M. (...)Novaro, V. Carcinogenesis. 33(3):509-518

"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320

"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320

"Neuroprotective actions of estradiol revisited" (2011) Azcoitia, I.; Arevalo, M.-A.; De Nicola, A.F.; Garcia-Segura, L.M. Trends in Endocrinology and Metabolism. 22(12):467-473

"Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects" (2011) Bottino, M.C.;Cerliani, J.P.;Rojas, P. (...)Lanari, C. Breast Cancer Research and Treatment. 126(3):621-636

"Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects" (2011) Bottino, M.C.;Cerliani, J.P.;Rojas, P. (...)Lanari, C. Breast Cancer Research and Treatment. 126(3):621-636

"Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration" (2009) De Nicola, A.F.;Labombarda, F.;Deniselle, M.C.G. (...)Schumacher, M. Frontiers in Neuroendocrinology. 30(2):173-187

"Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis" (2008) Giulianelli, S.;Cerliani, J.P.;Lamb, C.A. (...)Lanari, C. International Journal of Cancer. 123(11):2518-2531

"Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment" (2007) Montero Girard, G.;Vanzulli, S.I.;Cerliani, J.P. (...)Lanari, C. Breast Cancer Research. 9(2)

"Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation" (2006) Salatino, M.;Beguelin, W.;Peters, M.G. (...)Elizalde, P.V. Oncogene. 25(59):7723-7739

"Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model" (2005) Fabris, V.T.;Benavides, F.;Conti, C. (...)Lanari, C. Cancer Genetics and Cytogenetics. 161(2):130-139

"Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells" (2005) Proietti, C.;Salatino, M.;Rosemblit, C. (...)Elizalde, P.V. Molecular and Cellular Biology. 25(12):4826-4840

"Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleptides to type I insulin-like growth factor receptor rnRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity" (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Oncogene. 23(30):5161-5174

"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134

"Karyotypic evolution of four novel mouse mammary carcinoma cell lines. Identification of marker chromosomes by fluorescence in situ hybridization" (2003) Fabris, V.;Lamb, C.A.;Keck, C. (...)Lanari, C. Cancer Genetics and Cytogenetics. 142(1):36-45

"Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells" (2003) Labriola, L.;Salatino, M.;Proietti, C.J. (...)Elizalde, P.V. Molecular and Cellular Biology. 23(3):1095-1111

"Mechanisms of cell cycle arrest in response to TGF-β in progestin- dependent and -independent growth of mammary tumors" (2001) Salatino, M.;Labriola, L.;Schillaci, R. (...)Elizalde, P.V. Experimental Cell Research. 265(1):152-166

"Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells" (2001) Balãá, M.E.;Labriola, L.;Salatino, M. (...)Elizalde, P.V. Oncogene. 20(1):34-47

"Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice" (2001) Pazos, P.; Lanari, C.; Molinolo, A.A. Leukemia Research. 25(2):165-167

"Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice" (2001) Pazos, P.; Lanari, C.; Molinolo, A.A. Leukemia Research. 25(2):165-167

"Reversal of estrogen-resistance in murine mammary adenocarcinomas" (1999) Montecchia, M.F.; Molinolo, A.; Lanari, C. Breast Cancer Research and Treatment. 54(2):93-99

"Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas" (1999) Balañá, M.E.;Lupu, R.;Labriola, L. (...)Elizalde, P.V. Oncogene. 18(46):6370-6379

"Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice" (1998) Pazos, P.;Lanari, C.;Elizalde, P. (...)Molinolo, A.A. Carcinogenesis. 19(3):529-531

"Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo" (1997) Lanari, C.;Montecchia, M.F.;Pazos, P. (...)Mounolo, A.A. Medicina. 57(SUPPL 2):55-69

"Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c" (1997) Elizalde, P.V.; Balana, M.E.; Charreau, E.H. Medicina. 57(SUPPL 2):70-74

"Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas" (1995) Elizalde, P.V.;Guerra, F.K.;Gravano, M. (...)Lupu, R. Cancer Investigation. 13(2):173-180

"Insulin-like growth factor-I production and receptors in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice" (1990) Elizalde, P.V.;Lanari, C.;Bussmann, L. (...)Charreau, E.H. Journal of Experimental and Clinical Cancer Research. 9(4):193-203

"Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice" (1990) Elizalde, P.V.;Lanari, C.;Kordon, E. (...)Charreau, E.H. Breast Cancer Research and Treatment. 16(1):29-39

"Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice" (1990) Elizalde, P.V.;Lanari, C.;Kordon, E. (...)Charreau, E.H. Breast Cancer Research and Treatment. 16(1):29-39

"Role of ACTH on the effect of medroxyprogesterone in brain stem serotonin" (1978) Izquierdo, J.A.;Savini, C.;Borghi, E. (...)Justel, E. Pharmacological Research Communications. 10(7):643-656

Facultad de Ciencias Exactas y Naturales - Universidad de Buenos Aires - Argentina
Intendente Güiraldes 2160 - Ciudad Universitaria - C1428EGA - Tel. (54 11) 5285-8274

Biblioteca Campus Virtual Trámites Intranet Webmail Contacto UBA